Epidemiology and clinical features of retinoblastoma: A tertiary care center's experience in India [0.03%]
印度三级护理中心视网膜母细胞瘤的流行病学和临床特征
Maneya Padma,Nuthan Kumar,Prerana S Nesargi et al.
Maneya Padma et al.
Introduction: Retinoblastoma (RB) is a prototype of heritable cancers. It is more common in the lower socioeconomic strata. Delayed presentation significantly reduces the overall outcome. We have analyzed the epidemiologi...
Pediatric cancers in Bihar: A retrospective tertiary cancer center study [0.03%]
印度比哈尔邦的儿童癌症：一项回顾性三级癌症中心的研究
Avinash Pandey,Anjana Singh,Vijendra Kumar et al.
Avinash Pandey et al.
Background: There is lack of information regarding pattern of distribution of pediatric cancers in Bihar. Aim: The aim of this study is to identify the pattern of distribution of pediatric cancers. ...
The real-world experience with nivolumab in previously treated patients with advanced non-small cell lung cancer from a cancer center in India [0.03%]
印度一家癌症中心先前接受过治疗的晚期非小细胞肺癌患者使用纳武单抗的真实世界经验
Waseem Abbas,Rudra Prasad Acharya,Archit Pandit et al.
Waseem Abbas et al.
Background: PDL-1 inhibitors have emerged as the new standard of care for second line treatment of NSCLC. Methods: Eligible patients in...
Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer [0.03%]
表皮生长因子受体突变阳性晚期非小细胞肺癌的三线治疗
Vanita Noronha,Nikhil Pande,Amit Joshi et al.
Vanita Noronha et al.
Introduction: The treatment of lung cancer is not defined in the third-line setting and remains an unanswered question. Erlotinib is the only drug approved in the third-line setting. With the introduction of effective fir...
Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer [0.03%]
尼莫单抗联合调强放疗治疗无法手术且对铂类不耐受的局部晚期头颈部肿瘤患者
K Satish Srinivas,Raja Sundaram,C V Divyambika et al.
K Satish Srinivas et al.
Background: Outcomes with conventional treatment are poor in patients with squamous cell carcinoma of head and neck (SCCHN). Treatment options are further limited for patients ineligible to receive platinum-based chemothe...
Demography and treatment pattern of patients with head and neck carcinoma presenting to a tertiary care center in India: Need for urgent decentralization of cancer care [0.03%]
印度三级医疗中心头颈部肿瘤患者的流行病学及治疗模式：迫切需要分散化癌症治疗机构
Mihir N Chandarana,Prathamesh S Pai
Mihir N Chandarana
Aims: This study aims to report on the demographic profile and treatment pattern of head and neck cancer patients and impact of an early treatment decision on treatment. This study also aims to suggest recommendations to ...
Myeloma-associated amyloid arthropathy masquerading as seronegative arthritis [0.03%]
以负血清关节炎为表现的多发性骨髓瘤伴淀粉样变性关节病病例报告
Akanksha Garg,Pradeep Kumar,Ram Nawal Rao et al.
Akanksha Garg et al.
Adequacy of surgical margins in oral cancer patients with respect to various types of reconstruction [0.03%]
不同重建方式下口腔癌患者切缘充分性的研究
Apurva Garg,Manish Mair,Hitesh Singhavi et al.
Apurva Garg et al.
Background: Surgical margin is an important prognostic factor for oral cancers (oral squamous cell carcinoma [OSCC]). The correlation of margin with the type of reconstruction has never been studied. ...
Does preoperative CA-125 cutoff value and percent reduction in CA-125 levels correlate with surgical and survival outcome after neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer? - Our experience from a tertiary cancer institute [0.03%]
术前CA125截断值和新辅助化疗后CA125水平下降的百分比与晚期卵巢癌患者的手术及生存结局相关吗？- 来自一家三级癌症诊疗中心的经验报告
Monisha Gupta,Shilpa Mukesh Patel,Ruchi Arora et al.
Monisha Gupta et al.
Aim: The aim of the study is to evaluate percent fall in CA-125 levels after neoadjuvant chemotherapy (NAC) and preoperative CA-125 value to predict surgical and survival outcomes in women with advanced-stage epithelial o...
Primary malignant mediastinal germ cell tumors: A single institutional experience [0.03%]
原发纵隔生殖细胞肿瘤的诊治经验
Subhasis Mishra,Saroj Kumar Das Majumdar,Mukund Sable et al.
Subhasis Mishra et al.
Background: Primary mediastinal malignant germ cell tumour (PMMGCT) is rare with unsatisfactory prognosis and pose difficulty in management due to lack of guidelines. ...